Display options
Share it on

Enzyme Res. 2012;2012:659649. doi: 10.1155/2012/659649. Epub 2011 Oct 31.

Phosphatases: the new brakes for cancer development?.

Enzyme research

Qingxiu Zhang, Francois X Claret

Affiliations

  1. Department of Systems Biology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

PMID: 22121480 PMCID: PMC3206369 DOI: 10.1155/2012/659649

Abstract

The phosphatidylinositol 3-kinase (PI3K) pathway plays a pivotal role in the maintenance of processes such as cell growth, proliferation, survival, and metabolism in all cells and tissues. Dysregulation of the PI3K/Akt signaling pathway occurs in patients with many cancers and other disorders. This aberrant activation of PI3K/Akt pathway is primarily caused by loss of function of all negative controllers known as inositol polyphosphate phosphatases and phosphoprotein phosphatases. Recent studies provided evidence of distinct functions of the four main phosphatases-phosphatase and tensin homologue deleted on chromosome 10 (PTEN), Src homology 2-containing inositol 5'-phosphatase (SHIP), inositol polyphosphate 4-phosphatase type II (INPP4B), and protein phosphatase 2A (PP2A)-in different tissues with respect to regulation of cancer development. We will review the structures and functions of PTEN, SHIP, INPP4B, and PP2A phosphatases in suppressing cancer progression and their deregulation in cancer and highlight recent advances in our understanding of the PI3K/Akt signaling axis.

References

  1. Cell. 1997 Feb 21;88(4):435-7 - PubMed
  2. Cell. 1998 Oct 2;95(1):29-39 - PubMed
  3. Oncogene. 2000 Feb 24;19(9):1191-5 - PubMed
  4. Exp Hematol. 2003 Dec;31(12):1170-81 - PubMed
  5. Science. 1999 Mar 26;283(5410):2089-91 - PubMed
  6. Science. 2002 Dec 6;298(5600):1912-34 - PubMed
  7. Carcinogenesis. 2008 Jan;29(1):25-34 - PubMed
  8. Science. 1992 Aug 28;257(5074):1261-4 - PubMed
  9. J Clin Oncol. 2004 Jul 15;22(14):2954-63 - PubMed
  10. Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1182-7 - PubMed
  11. J Biol Chem. 2010 Nov 5;285(45):34493-502 - PubMed
  12. Science. 1998 Oct 9;282(5387):284-7 - PubMed
  13. Mol Cell Biol. 2002 Apr;22(7):2111-23 - PubMed
  14. J Immunol. 2006 Dec 15;177(12):8777-84 - PubMed
  15. Blood. 2001 Oct 1;98(7):2028-38 - PubMed
  16. J Biol Chem. 1995 Jan 6;270(1):214-7 - PubMed
  17. Genes Dev. 1998 Jun 1;12(11):1610-20 - PubMed
  18. Oncogene. 2004 Jan 8;23(1):49-57 - PubMed
  19. Oncotarget. 2011 Apr;2(4):321-8 - PubMed
  20. Cancer Res. 1997 Jun 1;57(11):2124-9 - PubMed
  21. Genomics. 1999 Dec 1;62(2):260-71 - PubMed
  22. J Biol Chem. 1993 Oct 15;268(29):21463-5 - PubMed
  23. Oncol Rep. 2004 Mar;11(3):655-9 - PubMed
  24. Genes Chromosomes Cancer. 2006 Nov;45(11):1033-40 - PubMed
  25. Oncogene. 2003 May 19;22(20):3113-22 - PubMed
  26. Dev Cell. 2009 Jul;17(1):9-26 - PubMed
  27. Mol Cell. 2005 Apr 1;18(1):13-24 - PubMed
  28. Cancer Res. 1998 Jan 15;58(2):204-9 - PubMed
  29. Cancer Cell. 2009 Aug 4;16(2):115-25 - PubMed
  30. Science. 1997 Mar 28;275(5308):1943-7 - PubMed
  31. Cell. 1987 Sep 25;50(7):1131-7 - PubMed
  32. Cell. 2006 Nov 17;127(4):759-73 - PubMed
  33. Genomics. 1996 Aug 15;36(1):168-70 - PubMed
  34. FEBS Lett. 2003 Jul 3;546(1):159-65 - PubMed
  35. Nature. 2004 Mar 18;428(6980):332-7 - PubMed
  36. Nature. 2001 Jan 4;409(6816):92-7 - PubMed
  37. Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14693-8 - PubMed
  38. EMBO J. 2007 Jan 24;26(2):402-11 - PubMed
  39. Nat Med. 2004 May;10(5):484-6 - PubMed
  40. Cell. 2005 Jun 17;121(6):837-48 - PubMed
  41. Nat Rev Drug Discov. 2005 Dec;4(12):988-1004 - PubMed
  42. Oncogene. 2008 Sep 18;27(41):5497-510 - PubMed
  43. Nat Genet. 1997 May;16(1):64-7 - PubMed
  44. J Cell Sci. 2008 Oct 15;121(Pt 20):3383-92 - PubMed
  45. Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):19867-72 - PubMed
  46. Biochim Biophys Acta. 2009 Jan;1795(1):1-15 - PubMed
  47. Mol Biol Cell. 2001 Jan;12(1):185-99 - PubMed
  48. Development. 2004 Apr;131(8):1663-77 - PubMed
  49. Eur J Hum Genet. 2001 Feb;9(2):121-9 - PubMed
  50. Trends Biochem Sci. 1999 May;24(5):186-91 - PubMed
  51. Clin Cancer Res. 2009 Oct 1;15(19):6301-8 - PubMed
  52. Nat Genet. 1998 Aug;19(4):348-55 - PubMed
  53. Oncogene. 1998 Sep 24;17(12):1557-65 - PubMed
  54. Blood. 1999 Mar 15;93(6):1922-33 - PubMed
  55. Breast Cancer Res. 2005;7(6):R1186-98 - PubMed
  56. Lung Cancer. 1999 Aug;25(2):87-93 - PubMed
  57. Oncogene. 2007 Mar 22;26(13):1959-70 - PubMed
  58. Clin Chem. 2009 Oct;55(10):1834-42 - PubMed
  59. Cancer Res. 2008 Aug 1;68(15):6084-91 - PubMed
  60. Hum Pathol. 2008 Jun;39(6):857-65 - PubMed
  61. Proc Natl Acad Sci U S A. 2010 Dec 21;107(51):22231-6 - PubMed
  62. Mol Cell Biol. 1994 Sep;14(9):5682-91 - PubMed
  63. Apoptosis. 2003 Jan;8(1):11-8 - PubMed
  64. Nat Cell Biol. 2004 Apr;6(4):308-18 - PubMed
  65. Proc Natl Acad Sci U S A. 1988 Mar;85(6):1768-71 - PubMed
  66. J Biol Chem. 1997 Apr 25;272(17):10998-1001 - PubMed
  67. FASEB J. 2010 Oct;24(10):3950-9 - PubMed
  68. J Virol. 1994 Jan;68(1):123-9 - PubMed
  69. EMBO J. 2001 Aug 1;20(15):4122-31 - PubMed
  70. Cancer Res. 2010 Dec 15;70(24):10474-84 - PubMed
  71. Cancer Biol Ther. 2003 Sep-Oct;2(5):471-6 - PubMed
  72. Virology. 2001 Nov 25;290(2):192-8 - PubMed
  73. Science. 2010 Oct 8;330(6001):228-31 - PubMed
  74. J Exp Med. 2010 Oct 25;207(11):2407-20 - PubMed
  75. J Biol Chem. 1997 Sep 19;272(38):23859-64 - PubMed
  76. Oncogene. 2006 Mar 2;25(9):1420-3 - PubMed
  77. Cancer Lett. 2001 Sep 10;170(1):1-13 - PubMed
  78. J Biol Chem. 2003 Oct 3;278(40):38628-36 - PubMed
  79. Cell. 2007 Jul 13;130(1):51-62 - PubMed
  80. Genes Dev. 1996 May 1;10(9):1084-95 - PubMed
  81. Mol Cell. 2011 Feb 18;41(4):471-9 - PubMed
  82. Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):3947-52 - PubMed
  83. Mol Cancer Ther. 2011 Jun;10(6):1093-101 - PubMed
  84. Cell. 2000 Feb 18;100(4):387-90 - PubMed
  85. Mol Cell. 2009 Mar 13;33(5):537-45 - PubMed
  86. Cell. 2007 Jul 13;130(1):21-4 - PubMed
  87. Oncogene. 2005 Nov 21;24(52):7746-55 - PubMed
  88. Oncogene. 2010 Jul 8;29(27):3933-41 - PubMed
  89. Nat Genet. 1997 Aug;16(4):333-4 - PubMed
  90. Blood. 1996 Oct 15;88(8):2833-40 - PubMed
  91. Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19300-5 - PubMed
  92. Oncogene. 2001 Apr 5;20(15):1892-9 - PubMed
  93. Endocr Relat Cancer. 2003 Jun;10(2):203-8 - PubMed
  94. Biochem Soc Trans. 2003 Jun;31(Pt 3):573-8 - PubMed
  95. Gene. 2006 Jul 5;376(1):152-61 - PubMed
  96. Trends Endocrinol Metab. 2008 Aug;19(6):223-30 - PubMed
  97. J Biol Chem. 1999 Mar 12;274(11):7489-94 - PubMed
  98. J Pathol. 2011 Apr;223(5):567-73 - PubMed
  99. Histol Histopathol. 2003 Oct;18(4):1313-9 - PubMed
  100. Cancer Res. 2011 Jan 15;71(2):572-82 - PubMed
  101. Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1689-93 - PubMed
  102. PLoS Biol. 2007 Aug;5(8):e202 - PubMed
  103. Curr Cancer Drug Targets. 2007 Sep;7(6):591-604 - PubMed
  104. EMBO J. 2006 Feb 22;25(4):727-38 - PubMed
  105. Cancer Cell. 2004 Feb;5(2):127-36 - PubMed
  106. Development. 2003 Dec;130(23):5569-78 - PubMed
  107. Sci China C Life Sci. 2009 Feb;52(2):135-46 - PubMed
  108. Mol Cell Biol. 1992 Aug;12(8):3346-55 - PubMed
  109. Mol Cell Biol. 2006 Apr;26(7):2832-44 - PubMed
  110. Blood. 2004 Jun 15;103(12):4536-44 - PubMed
  111. Nat Genet. 1997 Apr;15(4):356-62 - PubMed
  112. Cancer Cell. 2004 Jun;5(6):553-63 - PubMed
  113. J Biol Chem. 2007 Feb 23;282(8):5468-77 - PubMed
  114. Nat Cell Biol. 2010 Apr;12(4):372-9 - PubMed
  115. J Biol Chem. 1996 May 10;271(19):11059-62 - PubMed
  116. Tumour Biol. 2008;29(5):330-41 - PubMed
  117. Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15587-91 - PubMed
  118. Front Biosci. 2007 May 01;12:2836-48 - PubMed
  119. Oncogene. 2001 Jan 4;20(1):10-5 - PubMed

Publication Types

Grant support